The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Remember I posted this last night?
https://www.griproom.com/fun/about-griproom
Found at the bottom of this page:
Geoffrey Kelly 9 hours ago · 0 Likes
I read your comments about Blackrock - very interesting and disturbing.
I feel the same is happening at NCYT / ALNOV a company listed on AIM and the French Bourse
Also:
B2HS2L Just now (awaiting modulator approval)
I think you should consider David Stone writing a story about NCYT (ALNOV).
to see how the lessons learned in this article:
https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired
applies to NCYT
++++
Modulator did not approve.
https://www.griproom.com/fun/about-griproom
Found at the bottom of this page:
Geoffrey Kelly 9 hours ago · 0 Likes
I read your comments about Blackrock - very interesting and disturbing.
I feel the same is happening at NCYT / ALNOV a company listed on AIM and the French Bourse
Also:
B2HS2L Just now (awaiting modulator approval)
I think you should consider David Stone writing a story about NCYT (ALNOV).
to see how the lessons learned in this article:
https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired
applies to NCYT
By the same griproom author on a similar subject:
https://www.griproom.com/fun/gilead-is-the-next-celgene-similarities-between-the-celgene-buyout-and-gilead
No problem b2hs2l.
Maybe if you put a bit more flair and effort into your posts more people may notice them .
( only jesting ;)..
No offence taken Saintsmith.
I hope your research returns some other good stories you can share with us ;)
Any substance re T/O our SP would not be where it is,relax guys back to normal.
Sorry b2hs2l , I didn’t read that second link i read the first piece you posted and then once in the article I scrolled onto the second article about companies been bought out and thought it was worth sharing .
I didn’t realise you posted that earlier .
. Wasn’t trying to steel anyone’s thunder .
@11:37 today I posted
Thanks WiHe.
Plenty to ponder, on another GripRoom article here:
https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired
Laughing Out Loud
Casalajuma and the rest.
Has that article specifically been written for NCYT holders ;)
Very interesting read .
well under valued should be at leaast 750
I agree with Kaeren. The manipulations only go so far until the goal posts (& pitch!) moves for a reason.
I am glad we are held at 700 because of the limbo we are in between the chance of there being a contract, the risk of there not being one & all the range of possible sizes in between. The big money needs an irrefutable reason of measurable monetary benefit to move back up rather than the faith / belief we hold on to.
@Kaeren,
True...a contract would help....but what type of contract I ask?.....I'm feeling and indefinite working relationship between NCYT and the DHSC (NHS) is currently happening and evolving (COG UK)......we have seen the BoJo's goal posts change practically weekly....how will this equate into contract news I wonder?.....another question could be....are the news blackouts serving institutional agenda and agreements who knows?.....lot's to ponder
A contract Kitzie will "tickle" all holders.
Thanks WiHe.
Plenty to ponder, on another GripRoom article here:
https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired
Possibly and could happen...although RNS would have reflected buy out interest if that was the case by now....NCYT RNS is more suggesting of their M&A, which ties in more with their strategy.....trading volumes are low, which to me suggests more of a hold with some impatients going on.....the big influence on SP is the imbalance in trading with France/ Bourse dictating sentiment (currently 70/30) ....remember most strategy/ success has been UK led.....the question you must ask yourself more with this share is.....what will tickle the ****les of the French investor to get the French market going and taking this share to the next level?
Immensly useful articles for the PI. We must share our concerns with the www.sharesoc.org Notwithstanding other issues BR involved in manipulation of the stock before AA acquisition of Sirius Minerals. The sculdugery is appaling - IMO.
That's how it works:
https://www.griproom.com/fun/why-your-stock-is-always-red
https://www.griproom.com/fun/blackrock-is-trying-to-steal-gaslog-and-why-you-should-care